Tonix Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Highlights
August 10, 2023 16:30 ET
|
Tonix Pharmaceuticals Holding Corp.
Topline Results from Four CNS Clinical Trials Expected in the Third and Fourth Quarters of 2023 Fibromyalgia Topline Results Expected in the Fourth Quarter of 2023 for Phase 3 Potentially...
Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update
August 09, 2023 16:01 ET
|
Lumos Pharma, Inc.
Confirms Timing for Primary Outcome Data Readout for two Phase 2 OraGrowtH Trials in Q4 2023Late Breaking Abstract Accepted for Oral Presentation at ESPE 2023Encouraging Interim Data from OraGrowtH...
World Lab-on-a-Chip & Microfluidics Congress 2023: Where Innovations Meet Applications (Laguna Hills, United States - November 28-30, 2023)
August 02, 2023 07:33 ET
|
Research and Markets
Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The "Lab-on-a-Chip & Microfluidics World Congress 2023" conference has been added to ResearchAndMarkets.com's offering. Welcome to the 16th Annual...
Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly
July 31, 2023 08:01 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will host a Key Opinion Leader (KOL) webinar on August 8, 2023 at 12:00 pm Eastern...
Tonix Pharmaceuticals Announces Enrollment Initiated in the MGH Phase 2 ‘STROBE’ Study of TNX-1900 (Intranasal Potentiated Oxytocin) for the Treatment of Binge-Eating Disorder
July 31, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Preliminary Data Show that Oxytocin Decreases Impulsivity and Reduces Food Intake TNX-1900 (Intranasal Potentiated Oxytocin) May Serve as a Novel Neuroendocrine Treatment for Binge-Eating Disorder ...
Tonix Pharmaceuticals Announces Initiation of Enrollment in the MGH Phase 2 ‘POWER’ Study of TNX-1900 (Intranasal Potentiated Oxytocin) for the Treatment of Pediatric Obesity
July 10, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Preliminary Data Suggest that Oxytocin May Simultaneously Reduce Energy Intake and Increase Energy Expenditure TNX-1900 (Intranasal Potentiated Oxytocin) May Serve as a Novel Neuroendocrine...
Extracellular Vesicles 2023: Drug Delivery, Biologics & Therapeutics Conference (Orlando, Florida, United States - July 26-27, 2023)
July 03, 2023 04:38 ET
|
Research and Markets
Dublin, July 03, 2023 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles 2023: Drug Delivery, Biologics & Therapeutics" conference has been added to ResearchAndMarkets.com's offering.Welcome to...
Extracellular Vesicles Conference 2023: Technologies, Biomarker Cargo & Diagnostics (Orlando, Florida, United States - July 26-27, 2023)
June 28, 2023 05:08 ET
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles 2023: Technologies, Biomarker Cargo & Diagnostics" conference has been added to ResearchAndMarkets.com's offering.Welcome...
James Heffernan Receives HFMA Individual Achievement Award
June 27, 2023 10:30 ET
|
Healthcare Financial Management Association (HFMA)
NASHVILLE, Tenn., June 27, 2023 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today presented James L. Heffernan, FHFMA, MBA, with the 2023 Frederick C. Morgan...
Bitterroot Bio Launches Out of Stealth with $145 Million Series A Financing to Develop Transformative Medicines in Cardio-immunology
June 07, 2023 08:00 ET
|
Bitterroot Bio
Founders, Executive Team, and Advisors are recognized scientific and clinical pioneers in the fields of immunology and cardiology Series A financing co-led by ARCH Venture Partners and Deerfield...